Track ResMed Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

ResMed Inc. RMD.AX Open ResMed Inc. in new tab

32.21 AUD
P/E
22.30
EPS
1.45
Yield
1.08%
P/B
0.51
ROE
25.68
Beta
0.89
Target Price
47.68 AUD
Loading chart...
Key Metrics
Earnings dateApril 23, 2026
P/E22.30
EPS1.45
Book Value63.05
Price to Book0.51
Debt/Equity13.41
Growth
Revenue Growth0.11%
Earnings Growth0.15%
Estimates
Forward P/E17.87
Forward EPS1.81
Target Mean Price47.68
Dividend
Dividend Yield1.08%
Annual dividends0.35 AUD
Ex-Div. DateFeb. 11, 2026
Payout22.35%
5y avg Yield0.82%

DCF Valuation

Tweak assumptions to recompute fair value for ResMed Inc. (RMD.AX)
Currency: AUD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ResMed Inc. Logo ResMed Inc. Analysis (RMD.AX)

United States Health Care Official Website Stock

Is ResMed Inc. a good investment? ResMed Inc. (RMD.AX) is currently trading at 32.21 AUD. Market analysts have a consensus price target of 47.68 AUD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 22.30. This valuation is generally in line with the broader market.

Earnings Schedule: ResMed Inc. is expected to release its next earnings report on April 23, 2026. The market consensus estimate for Forward EPS is 1.81.

For income investors, ResMed Inc. pays a dividend yield of 1.08%. With a payout ratio of 22%, the dividend appears sustainable.

Investor FAQ

Does ResMed Inc. pay a dividend?

Yes, it pays an annual dividend of 0.35 AUD (1.08% yield).

What asset class is ResMed Inc.?

ResMed Inc. is classified as a Stock. You can compare it against 13 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be April 23, 2026. The company currently has a trailing EPS of 1.45.

Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Exchange Ticker
ASX (Australia) RMD.AX
FRA (Germany) RMD.F
MEX (Mexico) RMD.MX
VIE (Austria) RMD.VI
BER (Germany) RME.BE
DUS (Germany) RME.DU
FRA (Germany) RME.F
MUN (Germany) RME.MU
STU (Germany) RME.SG
FRA (Germany) RMEA.F
STU (Germany) RMEA.SG
SAO (Brazil) R1MD34.SA
PNK (United States) RSMDF
Dividend Yield

1.08% (5y avg: 0.82%)

Annual Dividends

0.35 AUD

Next ex. div date

Feb. 11, 2026

Payout Ratio

22.35%

Historical Dividends
Year Total Dividends
2027 0.06 AUD
2026 0.35 AUD
2025 0.35 AUD
2024 0.31 AUD
2023 0.28 AUD
2022 0.26 AUD
2021 0.25 AUD
2020 0.22 AUD
2019 0.19 AUD
2018 0.18 AUD
2017 0.19 AUD
2015 0.06 AUD
2014 0.11 AUD
2013 0.07 AUD
2012 0.03 AUD

Yearly aggregated dividends

Dividends

ResMed Inc.
Mar 19, 2026 Paid
Dividend
0.05922 AUD
ResMed Inc.
Dec 18, 2025 Paid
Dividend
0.0919 AUD
ResMed Inc.
Sep 18, 2025 Paid
Dividend
0.092676 AUD
ResMed Inc.
Jun 12, 2025 Paid
Dividend
0.080523 AUD

Historical Split Corporate Actions

Split Date Split Ratio to 1
March 8, 2000 2.000000
Sept. 9, 2005 2.000000
Aug. 12, 2010 2.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion